Multivitamin use may cut risk of chemo-induced neuropathy

September 13, 2017

(HealthDay)—Multivitamin use before diagnosis of breast cancer is associated with reduced risk of symptoms of chemotherapy-induced peripheral neuropathy, according to a study published online Sept. 1 in the Journal of the National Cancer Institute.

Gary R. Zirpoli, Ph.D., from the Roswell Park Cancer Institute in Buffalo, N.Y., and colleagues examined use of dietary supplements before and during treatment in relation to CIPN using data from questionnaires completed by 1,225 patients. The authors assessed supplement use in relation to CIPN; they used the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE v. 3.0) and the self-reported Functional Assessment of Cancer Therapy/Gynecologic Oncology Group Neurotoxicity (FACT/GOG-Ntx) subscale.

The researchers found that there was an association for multivitamin use before diagnosis with reduced symptoms of CIPN (CTCAE-adjusted odds ratio, 0.6 [95 percent confidence interval, 0.42 to 0.87]; FACT/GOG-Ntx-adjusted OR, 0.78 [95 percent confidence interval, 0.61 to 1]). There was a marginal inverse correlation for use during treatment with CIPN (CTCAE-adjusted odds ratio, 0.73 [95 percent confidence interval, 0.49 to 1.08]; FACT/GOG-Ntx-adjusted odds ratio, 0.77 [95 percent confidence interval, 0.6 to 0.99]). There was no significant correlation for other supplement use, either before diagnosis or during treatment, with CIPN.

"Multivitamin use could be a surrogate for other related behaviors that are the actual drivers of the association with reduced CIPN," the authors write.

The study was partially funded by Amgen.

Explore further: Occult cancer found in ~5 percent with unprovoked VTE

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Occult cancer found in ~5 percent with unprovoked VTE

August 23, 2017
(HealthDay)—About one in 20 patients with unprovoked venous thromboembolism (VTE) have occult cancer detected within one year, according to a review published online Aug. 22 in the Annals of Internal Medicine.

Radioiodine therapy for thyroid cancer doesn't up stroke risk

August 21, 2017
(HealthDay)—Radioiodine (I-131) therapy for thyroid cancer is not associated with increased risk of stroke, according to a study published online Aug. 16 in Head & Neck.

Endometrial ablation doesn't increase cancer risk

August 14, 2017
(HealthDay)—For women in Finland, endometrial ablation is not associated with increased risk of endometrial or breast cancer, according to a study published in the September issue of Obstetrics & Gynecology.

Survey puts disabling chemotherapy side effect in focus

June 5, 2017
Thousands of Australian cancer survivors experience chemotherapy-induced peripheral neuropathy (CIPN), but little is known about its impact on a national level.

Stem cell factor tied to reduced risk of cardiac events, death

September 1, 2017
(HealthDay)—High levels of stem cell factor (SCF) are associated with reduced risk of mortality and cardiovascular events, according to a study published online Aug. 26 in the Journal of Internal Medicine.

No link for tea, coffee intake with barrett's esophagus

May 5, 2016
(HealthDay)—After adjustment for confounding variables there is no correlation between the risk of Barrett's esophagus (BE) and tea or coffee consumption, according to a study published in the May issue of Clinical Gastroenterology ...

Recommended for you

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.